The Relevance of Reproducibility for Drug Development

Description

Introduction and analysis of the current reproducibility issues by Leonard Freedman PhD, Chief Scientific Officer at Frederick National Laboratory for Cancer Research

Want to know more?

The drug development field is facing high irreproducibility rates. To address and discuss reproducibility issues and improvement of measures ensuring more robust data quality along the drug development pipeline, EATRIS, the European Infrastructure for Translational Medicine, is running this webinar series. During this first webinar, we will briefly introduce EATRIS, along with the EATRIS Quality Initiative, and get a thorough introduction and analysis of the current reproducibility issues by Leonard Freedman PhD, Chief Scientific Officer at Frederick National Laboratory for Cancer Research

Quality and Reproducibility Webinar 1 – The Relevance of Reproducibility for Drug Development (youtube.com)